company background image
RVTY logo

Revvity NYSE:RVTY Stock Report

Last Price

US$104.90

Market Cap

US$13.0b

7D

-4.0%

1Y

-15.2%

Updated

18 Mar, 2024

Data

Company Financials +

RVTY Stock Overview

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally.

RVTY fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Revvity, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Revvity
Historical stock prices
Current Share PriceUS$104.90
52 Week HighUS$139.04
52 Week LowUS$79.50
Beta1.1
1 Month Change2.38%
3 Month Change0.16%
1 Year Change-15.25%
3 Year Change-18.13%
5 Year Change10.97%
Change since IPO3,066.79%

Recent News & Updates

We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Feb 28
We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Feb 13
Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Recent updates

We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Feb 28
We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Feb 13
Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

Jan 19
Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Jan 04
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Revvity: More Than A Name Change Is Needed For PerkinElmer

Dec 29

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Dec 20
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Is Revvity (NYSE:RVTY) Using Too Much Debt?

Oct 07
Is Revvity (NYSE:RVTY) Using Too Much Debt?

Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade)

Oct 04

At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?

Sep 22
At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued

Aug 17
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued

Revvity: New Name - But New Investment Outlook? Reiterate Buy

Jul 18

Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly

Jul 03
Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly

What Does Revvity, Inc.'s (NYSE:RVTY) Share Price Indicate?

Jun 17
What Does Revvity, Inc.'s (NYSE:RVTY) Share Price Indicate?

Calculating The Fair Value Of Revvity, Inc. (NYSE:PKI)

May 16
Calculating The Fair Value Of Revvity, Inc. (NYSE:PKI)

We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt

Mar 28
We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt

When Should You Buy PerkinElmer, Inc. (NYSE:PKI)?

Mar 13
When Should You Buy PerkinElmer, Inc. (NYSE:PKI)?

PerkinElmer Q4 2022 Earnings Preview

Feb 13

A Look At The Intrinsic Value Of PerkinElmer, Inc. (NYSE:PKI)

Feb 10
A Look At The Intrinsic Value Of PerkinElmer, Inc. (NYSE:PKI)

PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate

Jan 31

Danaher earnings weigh on other life sciences tools, services companies

Jan 24

PerkinElmer says Q4 results will meet or exceed prior guidance

Jan 09

PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet

Dec 27
PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet

Is It Time To Consider Buying PerkinElmer, Inc. (NYSE:PKI)?

Dec 12
Is It Time To Consider Buying PerkinElmer, Inc. (NYSE:PKI)?

PerkinElmer receives FDA approval for EONIS assay for spinal muscular atrophy in newborns

Nov 14

PerkinElmer reports mixed Q3 earnings, initiates Q4 and updates FY22 pro forma guidance

Nov 08

PerkinElmer, Inc.'s (NYSE:PKI) Intrinsic Value Is Potentially 48% Above Its Share Price

Oct 28
PerkinElmer, Inc.'s (NYSE:PKI) Intrinsic Value Is Potentially 48% Above Its Share Price

PerkinElmer declares $0.07 dividend

Oct 27

PerkinElmer expects Q3 earnings to exceed prior outlook

Oct 17

PerkinElmer gets FDA approval for T-Cell Select kit to automate TB test

Sep 22

What Is PerkinElmer, Inc.'s (NYSE:PKI) Share Price Doing?

Sep 12
What Is PerkinElmer, Inc.'s (NYSE:PKI) Share Price Doing?

PerkinElmer: Focusing, Appealing

Sep 01

Is PerkinElmer (NYSE:PKI) A Risky Investment?

Aug 27
Is PerkinElmer (NYSE:PKI) A Risky Investment?

Shareholder Returns

RVTYUS Life SciencesUS Market
7D-4.0%-1.5%-0.1%
1Y-15.2%5.9%28.4%

Return vs Industry: RVTY underperformed the US Life Sciences industry which returned 5.9% over the past year.

Return vs Market: RVTY underperformed the US Market which returned 28.4% over the past year.

Price Volatility

Is RVTY's price volatile compared to industry and market?
RVTY volatility
RVTY Average Weekly Movement3.7%
Life Sciences Industry Average Movement7.2%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: RVTY has not had significant price volatility in the past 3 months.

Volatility Over Time: RVTY's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193711,500Prahlad Singhhttps://www.revvity.com

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Revvity, Inc. Fundamentals Summary

How do Revvity's earnings and revenue compare to its market cap?
RVTY fundamental statistics
Market capUS$12.96b
Earnings (TTM)US$179.50m
Revenue (TTM)US$2.75b

72.2x

P/E Ratio

4.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RVTY income statement (TTM)
RevenueUS$2.75b
Cost of RevenueUS$1.21b
Gross ProfitUS$1.54b
Other ExpensesUS$1.36b
EarningsUS$179.50m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.45
Gross Margin55.98%
Net Profit Margin6.53%
Debt/Equity Ratio49.5%

How did RVTY perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

19%

Payout Ratio

Does RVTY pay a reliable dividends?

See RVTY dividend history and benchmarks
When do you need to buy RVTY by to receive an upcoming dividend?
Revvity dividend dates
Ex Dividend DateApr 18 2024
Dividend Pay DateMay 10 2024
Days until Ex dividend30 days
Days until Dividend pay date52 days

Does RVTY pay a reliable dividends?

See RVTY dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.